Search

This study investigates the antiviral efficacy of chitosan‐stabilized silver nanoparticles (AgNPs) against the Foot‐and‐Mouth Disease virus (FMDV), a highly contagious pathogen affecting cloven‐hoofed animals. In vitro experiments demonstrated that AgNPs effectively inhibited FMDV replication in a dose‐dependent manner. At a concentration of 1.56 μg/ml, AgNPs exhibited no cytotoxicity to baby hamster kidney 21 (BHK21) cells while achieving complete deactivation of FMDV at a titer of 103 TCID50 and inhibiting viral growth at a titer of 104 TCID50. These findings suggest the potential of silver nanoparticles as a novel disinfectant for controlling FMDV transmission and preventing disease outbreaks. [ABSTRACT FROM AUTHOR]

Dengue fever pandemic caused by dengue virus has been claimed for many lives, however, no specific treatment is available. Prevention based on vector control posed to be the most effective measure so far. The application of chitosan stabilized silver nanoparticle (AgNPs) to control larvae and adult mosquitoes has recently discovered, but their ability to inhibit Dengue virus has scarcely discussed. In this study, chitosan stabilized AgNPs have been prepared and tested against dengue virus type 1. The results showed that chitosan stabilized AgNPs can inhibit 96.66% and 98.33% dengue virus type 1 at 12.50 ppm and 25.00 ppm, respectively, without any toxicity to BHKFcÉŁ cells. This study confirms that chitosan stabilized AgNPs have a highly antiviral ability against dengue virus in addition to its mosquitocidal properties. This allows one to control both virus and vector simultaneously. The study suggested that chitosan stabilized AgNPs could be an effective tool to prevent the dengue epidemic. [ABSTRACT FROM AUTHOR]